INKmune — Full data
Q4 2026
Final data analysis is underway, and release is expected in Q4 2026.Source filing
INMB biotech catalysts & pipeline
INMUNE BIO INC · Data as of 2026-10-25
Upcoming catalysts
CORDStrom™ (Ebstrocel™) — NDA/BLA submission
Feb 2027
The company has updated its regulatory submission strategy, as faster-than-expected manufacturing progress supports a full MAA submission in early February 2027, with potential UK approval in mid-2027, subject to MHRA review.Source filing
CORDStrom™ (Ebstrocel™) — NDA/BLA submission
Q2 2027
Subject to feedback from that meeting, the Company plans to submit a Biologics License Application (BLA) in the second quarter of 2027, seeking traditional or accelerated approval, as appropriate.Source filing
CORDStrom™ (Ebstrocel™) — Regulatory decision
mid-2027
The company has updated its regulatory submission strategy, as faster-than-expected manufacturing progress supports a full MAA submission in early February 2027, with potential UK approval in mid-2027, subject to MHRA review.Source filing